Status:
COMPLETED
Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients
Lead Sponsor:
Cairo University
Conditions:
Anesthesia Morbidity
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.
Eligibility Criteria
Inclusion
- end stage renal disease, for living donor renal transplantation
Exclusion
- severe cardiac or hepatic dysfunction, re-transplantation, coagulopathy
Key Trial Info
Start Date :
October 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03306914
Start Date
October 15 2017
End Date
February 1 2019
Last Update
January 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt